Primary |
Hepatitis C |
70.8% |
Product Used For Unknown Indication |
16.8% |
Hiv Infection |
2.1% |
Hypertension |
2.0% |
Anaemia |
1.5% |
Urinary Tract Infection |
1.3% |
Haemorrhage |
0.7% |
Schizophrenia |
0.7% |
Depression |
0.6% |
Pulmonary Arterial Hypertension |
0.6% |
Burn Oesophageal |
0.4% |
Diabetes Mellitus |
0.4% |
Sleep Disorder |
0.4% |
Hepatic Cirrhosis |
0.3% |
Hypothyroidism |
0.3% |
Antiviral Prophylaxis |
0.2% |
Anxiety |
0.2% |
Blood Cholesterol Increased |
0.2% |
Chronic Obstructive Pulmonary Disease |
0.2% |
Diarrhoea |
0.2% |
|
Rash |
24.6% |
Drug Rash With Eosinophilia And Systemic Symptoms |
12.3% |
Anaemia |
6.5% |
Pruritus |
6.5% |
Nausea |
5.8% |
Pancytopenia |
5.1% |
General Physical Health Deterioration |
4.3% |
Anal Fissure |
3.6% |
Pancreatitis Acute |
3.6% |
Asthenia |
2.9% |
Blood Creatinine Increased |
2.9% |
Drug Eruption |
2.9% |
Pyrexia |
2.9% |
Rectal Haemorrhage |
2.9% |
Anxiety |
2.2% |
Death |
2.2% |
Depression |
2.2% |
Dermatitis Exfoliative |
2.2% |
Diarrhoea |
2.2% |
Diarrhoea Haemorrhagic |
2.2% |
|
Secondary |
Hepatitis C |
90.0% |
Product Used For Unknown Indication |
5.7% |
Chronic Hepatitis C |
2.5% |
Antiretroviral Therapy |
0.7% |
Hepatitis |
0.7% |
Viral Hepatitis Carrier |
0.4% |
|
Rash |
19.7% |
Vomiting |
16.4% |
Pruritus |
6.6% |
Nausea |
4.9% |
Paranoia |
4.9% |
Rash Pruritic |
4.9% |
Deep Vein Thrombosis |
3.3% |
Hearing Impaired |
3.3% |
Neutrophil Count Decreased |
3.3% |
Off Label Use |
3.3% |
Pain |
3.3% |
Rectal Haemorrhage |
3.3% |
Sleep Disorder |
3.3% |
Suicidal Ideation |
3.3% |
Swelling Face |
3.3% |
Viral Load Increased |
3.3% |
Visual Impairment |
3.3% |
Yellow Skin |
3.3% |
Abdominal Pain Upper |
1.6% |
Asthenia |
1.6% |
|
Concomitant |
|
Drug Rash With Eosinophilia And Systemic Symptoms |
25.0% |
Acute Generalised Exanthematous Pustulosis |
12.5% |
Agranulocytosis |
12.5% |
Cerebral Haemorrhage |
12.5% |
Hepatic Encephalopathy |
12.5% |
Pancreatitis |
12.5% |
Vomiting |
12.5% |
|